Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
The number of people working or looking for work in the U.S. is near a four-decade low, and some experts believe that the opioid epidemic has played a key role in keeping a lid on participation.
According to Jeff Korzenik, chief investment adviser at Fifth Third Bank, the abuse of painkillers that has gripped the nation could be at the heart of a weaker reading of labor-force participation....More>>>
Sometimes I discuss stocks which sit out of my comfort zone, simply because they have a few characteristics which could be of interest to any kind of investor but don’t necessarily fit my portfolio. For example a blue chip stock which has features of positive capital gains combined with interesting dividend. In this case I am talking about Accenture (NYSE:ACN). A little bit more than a year....More>>>
Boston, MA, based Investment company Adage Capital Partners Gp Llc buys Deere, Puma Biotechnology Inc, Abbott Laboratories, Illinois Tool Works Inc, Morgan Stanley, Facebook Inc, General Electric Co, Burlington Stores Inc, PVH Corp, American Express Co, sells St Jude Medical Inc, Wells Fargo, Johnson Controls International PLC, Humana Inc, Hanesbrands Inc during the 3-months ended 2017-03-31, according....More>>>
&l;p&g;&l;img class=&q;size-full wp-image-1343&q; src=&q;http://blogs-images.forbes.com/mikescott/files/2018/01/CSP.jpg?width=960&q; alt=&q;&q; data-height=&q;445&q; data-width=&q;1000&q;&g; The Masdar-backed Gemasolar concentrated solar power plant in Spain. A similar plant will be open in the UAE in the next few years.
Even in the Middle East, home to some of the world&a;rsquo;s largest....More>>>
Media stories about Conatus Pharmaceuticals (NASDAQ:CNAT) have trended somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Conatus Pharmaceuticals earned a coverage....More>>>
The title of this article may generate strong responses from some, who will reply: “never!” And indeed, if a value trap is defined as a stock that is not a value, then clearly a value trap is never a value. (There aren’t many rich dialetheists on Wall Street.) But let’s take a more nuanced view of a value trap and follow Investopedia.com in defining a value trap, which I....More>>>
Legendary investor Bill Miller is the former chairman and chief investment officer of Legg Mason Capital Management. He has been named fund manager of the decade by Morningstar and ranked as the top 30 most influential people in investing by SmartMoney. Below is an edited summary of his interview with The Investor’s Podcast where he talks about determining the intrinsic value of various....More>>>
Brokerages forecast that McDermott International (NYSE:MDR) will post $0.09 earnings per share for the current quarter, according to Zacks. Two analysts have made estimates for McDermott International’s earnings, with the lowest EPS estimate coming in at $0.07 and the highest estimate coming in at $0.11. McDermott International reported earnings of $0.13 per share in the same quarter last....More>>>
Laboratory Corp. of America (NYSE: LH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. <
Achaogen (NASDAQ:AKAO) is a clinical-stage biotechnology company specializing in creating antibiotics to treat MDR (multidrug resistant) bacteria. Its lead candidate, plazomicin, recently was recommended for approval for cUTI (complicated urinary tract infections) on May 2 by an FDA advisory com
News coverage about McDermott International (NYSE:MDR) has trended somewhat positive on Monday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negati
Media stories about Conatus Pharmaceuticals (NASDAQ:CNAT) have trended somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scal